Re: Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder

被引：0
|
作者：
Kaplan, Steven A.
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 208卷 / 04期
关键词：
D O I：
10.1097/JU.0000000000002868
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：908 / 908
页数：1
相关论文
共 50 条
  • [31] Review of the Efficacy and Safety of Fesoterodine for Treating Overactive Bladder and Urgency Urinary Incontinence in Elderly Patients
    Wagg, Adrian
    Oelke, Matthias
    Angulo, Javier C.
    Scholfield, David
    Arumi, Daniel
    DRUGS & AGING, 2015, 32 (02) : 103 - 125
  • [32] Review of the Efficacy and Safety of Fesoterodine for Treating Overactive Bladder and Urgency Urinary Incontinence in Elderly Patients
    Adrian Wagg
    Matthias Oelke
    Javier C. Angulo
    David Scholfield
    Daniel Arumi
    Drugs & Aging, 2015, 32 : 103 - 125
  • [33] Re: Efficacy and Safety of Fesoterodine Treatment for Overactive Bladder Symptoms in Elderly Women with and without Hypertension Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2019, 201 (03): : 420 - 421
  • [34] New Perspectives of Treatment With Fesoterodine Fumarate in Patients With Overactive Bladder
    Garcia-Baquero, R.
    Madurga, B.
    Garcia, M. V.
    Fernandez, M. A.
    Rosety, J. M.
    Alvarez-Ossorio, J. L.
    ACTAS UROLOGICAS ESPANOLAS, 2013, 37 (02): : 83 - 91
  • [35] Re: Long-Term Safety, Tolerability and Efficacy of Flexible-Dose Fesoterodine in Elderly Patients with Overactive Bladder: Open-Label Extension of the SOFIA Trial Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2014, 192 (06): : 1766 - 1766
  • [36] Role of fesoterodine in the treatment of overactive bladder
    Mansfield, Kylie J.
    RESEARCH AND REPORTS IN UROLOGY, 2010, 2 : 1 - 9
  • [37] Trends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada
    Minhas, Rajwant
    Tadrous, Mina
    Elterman, Dean
    Gomes, Tara
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 (05) : 1693 - 1700
  • [38] Trends in the use of older overactive bladder agents and uptake of fesoterodine and mirabegron in Canada
    Gibson, William
    Wagg, Adrian
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 (08) : 2977 - 2978
  • [39] Clinical Efficacy, Safety, and Tolerability of Once-Daily Fesoterodine in Subjects with Overactive Bladder (vol 52, pg 1204, 2007)
    Chapple, Christopher
    Van Kerrebroeck, Philip
    Tubaro, Andrea
    Haag-Molkenteller, Cornelia
    Forst, Hans-Theo
    Massow, Ute
    Wang, Joseph
    Brodsky, Marina
    EUROPEAN UROLOGY, 2009, 56 (01) : 236 - 236
  • [40] Re: A Pooled Analysis of the Efficacy of Fesoterodine for the Treatment of Overactive Bladder, and the Relationship between Safety, Co-Morbidity and Polypharmacy in Patients Aged 65 Years or Older Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2018, 200 (03): : 477 - 478
12345